1 |
Bae, Y. S., Kang, S. W., Seo, M. S., Baines, I. C., Tekle, E., Chock, P. B. and Rhee, S. G. (1997) Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272, 217-221.
DOI
ScienceOn
|
2 |
Mahadev, K., Zilbering, A., Zhu, L. and Goldstein, B. J. (2001) Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J. Biol. Chem. 276, 21938-21942.
DOI
ScienceOn
|
3 |
Meng, T. C., Fukada, T. and Tonks, N. K. (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell. 9, 387-399.
DOI
ScienceOn
|
4 |
Ruiz-Gines, J. A., Lopez-Ongil, S., Gonzalez-Rubio, M., Gonzalez-Santiago, L., Rodriguez-Puyol, M. and Rodriguez- Puyol, D. (2000) Reactive oxygen species induce proliferation of bovine aortic endothelial cells. J. Cardiovasc. Pharmacol. 35, 109-113.
DOI
ScienceOn
|
5 |
Zanetti, M., Katusic, Z. S. and O'Brien, T. (2002) Adenoviral-mediated overexpression of catalase inhibits endothelial cell proliferation. Am. J. Physiol. Heart. Circ. Physiol. 283, H2620-2626.
DOI
|
6 |
Barry-Lane, P. A., Patterson, C., van der Merwe, M., Hu, Z., Holland, S. M., Yeh, E. T. and Runge, M. S. (2001) p47phox is required for atherosclerotic lesion progression in ApoE(−/−) mice. J. Clin. Invest. 108, 1513-1522.
DOI
|
7 |
Schroder, K., Vecchione, C., Jung, O., Schreiber, J. G., Shiri-Sverdlov, R., van Gorp, P. J., Busse, R. and Brandes, R. P. (2006) Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. Free. Radic. Biol. Med. 41, 1353-1360.
DOI
ScienceOn
|
8 |
Choi, J. H., Jeon, H. J., Park, J. G., Sonn, S. K., Lee, M. R., Lee, M. N., You, H. J., Kim, G. Y., Kim, J. H., Lee, M. H., Kwon, O. S., Nam, K. H., Kim, H. C., Jeong, T. S., Lee, W. S. and Oh, G. T. (2010) Anti-atherogenic effect of BHBTZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice. Atherosclerosis. 212, 146-152.
DOI
ScienceOn
|
9 |
Choi, J. H., Park, J. G., Jeon, H. J., Kim, M. S., Lee, M. R., Lee, M. N., Sonn, S., Kim, J. H., Lee, M. H., Choi, M. S., Park, Y. B., Kwon, O. S., Jeong, T. S., Lee, W. S., Shim, H. B., Shin, D. H. and Oh, G. T. (2011) HMB-TZD attenuates atherosclerosis possibly by reducing monocyte recruitment to the lesion. Exp. Mol. Med. (In press).
|
10 |
Rhee, S. G., Chang, T. S., Bae, Y. S., Lee, S. R. and Kang, S. W. (2003) Cellular regulation by hydrogen peroxide. J. Am. Soc. Nephrol. 14, S211-215.
DOI
ScienceOn
|
11 |
Wood, Z. A., Poole, L. B. and Karplus, P. A. (2003) Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300, 650-653.
DOI
ScienceOn
|
12 |
Babior, B. M. (1999) NADPH oxidase: an update. Blood. 93, 1464-1476.
|
13 |
Lambeth, J. D. (2002) Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr. Opin. Hematol. 9, 11-17.
DOI
ScienceOn
|
14 |
Cai, H. (2005) Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc. Res. 68, 26-36.
DOI
ScienceOn
|
15 |
Davies, M. J., Richardson, P. D., Woolf, N., Katz, D. R. and Mann, J. (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br. Heart. J. 69, 377-381.
DOI
|
16 |
Brandes, R. P. and Kreuzer, J. (2005) Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc. Res. 65, 16-27.
DOI
ScienceOn
|
17 |
Wittchen, E. S. (2009) Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front. Biosci. 14, 2522-2545.
|
18 |
Khan, B. V., Parthasarathy, S. S., Alexander, R. W. and Medford, R. M. (1995) Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95, 1262-1270.
DOI
ScienceOn
|
19 |
Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J. and Fogelman, A. M. (1990) Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A 87, 5134-5138.
DOI
ScienceOn
|
20 |
Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, M., Fogelman, A. M. and Lusis, A. J. (1990) Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344, 254-257.
DOI
ScienceOn
|
21 |
Lyons, T. J. (1993) Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am. J. Cardiol. 71, 26B-31B.
DOI
ScienceOn
|
22 |
Shibata, N. and Glass, C. K. (2009) Regulation of macrophage function in inflammation and atherosclerosis. J. Lipid. Res. 50 Suppl, S277-281.
DOI
|
23 |
Madamanchi, N. R., Vendrov, A. and Runge, M. S. (2005) Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 29-38.
|
24 |
Glass, C. K. and Witztum, J. L. (2001) Atherosclerosis. the road ahead. Cell. 104, 503-516.
DOI
ScienceOn
|
25 |
Li, H., Witte, K., August, M., Brausch, I., Godtel-Armbrust, U., Habermeier, A., Closs, E. I., Oelze, M., Munzel, T. and Forstermann, U. (2006) Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. J. Am. Coll. Cardiol 47, 2536-2544.
DOI
ScienceOn
|
26 |
Cai, H. (2005) NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ. Res. 96, 818-822.
DOI
ScienceOn
|
27 |
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R. A., Warnholtz, A., Meinertz, T., Griendling, K., Harrison, D. G., Forstermann, U. and Munzel, T. (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88, E14-22.
DOI
ScienceOn
|
28 |
Warnholtz, A., Nickenig, G., Schulz, E., Macharzina, R., Brasen, J. H., Skatchkov, M., Heitzer, T., Stasch, J. P., Griendling, K. K., Harrison, D. G., Bohm, M., Meinertz, T. and Munzel, T. (1999) Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99, 2027-2033.
DOI
ScienceOn
|
29 |
Forstermann, U. (2008) Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat. Clin. Pract. Cardiovasc. Med. 5, 338-349.
DOI
ScienceOn
|
30 |
Sorescu, D., Weiss, D., Lassegue, B., Clempus, R. E., Szocs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D., Taylor, W. R. and Griendling, K. K. (2002) Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105, 1429-1435.
DOI
ScienceOn
|
31 |
Klouche, M., May, A. E., Hemmes, M., Messner, M., Kanse, S. M., Preissner, K. T. and Bhakdi, S. (1999) Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers. Arterioscler. Thromb. Vasc. Biol. 19, 784-793.
DOI
ScienceOn
|
32 |
Charo, I. F. and Taub, R. (2011) Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat. Rev. Drug. Discov. 10, 365-376.
DOI
ScienceOn
|
33 |
Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., Gillespie, C., Go, A., Greenlund, K., Haase, N., Hailpern, S., Ho, P. M., Howard, V., Kissela, B., Kittner, S., Lackland, D., Lisabeth, L., Marelli, A., McDermott, M. M., Meigs, J., Mozaffarian, D., Mussolino, M., Nichol, G., Roger, V. L., Rosamond, W., Sacco, R., Sorlie, P., Stafford, R., Thom, T., Wasserthiel-Smoller, S., Wong, N. D. and Wylie-Rosett, J. (2010) Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121, 948-954.
DOI
ScienceOn
|
34 |
Ross, R. (1999) Atherosclerosis--an inflammatory disease. N. Engl. J. Med. 340, 115-126.
DOI
ScienceOn
|
35 |
Libby, P. (2002) Inflammation in atherosclerosis. Nature 420, 868-874.
DOI
ScienceOn
|
36 |
Navab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., Edwards, P. A. and Fogelman, A. M. (1996) The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler. Thromb. Vasc. Biol. 16, 831-842.
DOI
ScienceOn
|
37 |
Navab, M., Ananthramaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., Berliner, J. A., Lusis, A. J. and Fogelman, A. M. (2004) The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J. Lipid. Res. 45, 993-1007.
DOI
ScienceOn
|
38 |
Vora, D. K., Fang, Z. T., Liva, S. M., Tyner, T. R., Parhami, F., Watson, A. D., Drake, T. A., Territo, M. C. and Berliner, J. A. (1997) Induction of P-selectin by oxidized lipoproteins. Separate effects on synthesis and surface expression. Circ. Res. 80, 810-818.
DOI
ScienceOn
|
39 |
Nam, K. H., Choi, J. H., Seo, Y. J., Lee, Y. M., Won, Y. S., Lee, M. R., Lee, M. N., Park, J. G., Kim, Y. M., Kim, H. C., Lee, C. H., Lee, H. K., Oh, S. R. and Oh, G. T. (2006) Inhibitory effects of tilianin on the expression of inducible nitric oxide synthase in low density lipoprotein receptor deficiency mice. Exp. Mol. Med. 38, 445-452.
DOI
ScienceOn
|
40 |
Takei, A., Huang, Y. and Lopes-Virella, M. F. (2001) Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL. Atherosclerosis 154, 79-86.
DOI
ScienceOn
|
41 |
Steinhubl, S. R. (2008) Why have antioxidants failed in clinical trials? Am. J. Cardiol. 101, 14D-19D.
|
42 |
Martinez-Pinna, R., Ramos-Mozo, P., Madrigal-Matute, J., Blanco-Colio, L. M., Lopez, J. A., Calvo, E., Camafeita, E., Lindholt, J. S., Meilhac, O., Delbosc, S., Michel, J. B., de Ceniga, M. V., Egido, J. and Martin-Ventura, J. L. (2011) Identification of peroxiredoxin-1 as a novel biomarker of abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 31, 935-943.
DOI
ScienceOn
|
43 |
Rhee, S. G. (2006) Cell signaling. H2O2, a necessary evil for cell signaling. Science 312, 1882-1883.
DOI
ScienceOn
|
44 |
Moon, E. Y., Noh, Y. W., Han, Y. H., Kim, S. U., Kim, J. M., Yu, D. Y. and Lim, J. S. (2006) T lymphocytes and dendritic cells are activated by the deletion of peroxiredoxin II (Prx II) gene. Immunol. Lett. 102, 184-190.
DOI
ScienceOn
|
45 |
Yang, C. S., Lee, D. S., Song, C. H., An, S. J., Li, S., Kim, J. M., Kim, C. S., Yoo, D. G., Jeon, B. H., Yang, H. Y., Lee, T. H., Lee, Z. W., El-Benna, J., Yu, D. Y. and Jo, E. K. (2007) Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin- induced lethal shock. J. Exp. Med. 204, 583-594.
DOI
ScienceOn
|
46 |
Espinola-Klein, C., Rupprecht, H. J., Bickel, C., Schnabel, R., Genth-Zotz, S., Torzewski, M., Lackner, K., Munzel, T. and Blankenberg, S. (2007) Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis. Am. J. Cardiol. 99, 808-812.
DOI
ScienceOn
|
47 |
Urbonavicius, S., Lindholt, J. S., Vorum, H., Urbonaviciene, G., Henneberg, E. W. and Honore, B. (2009) Proteomic identification of differentially expressed proteins in aortic wall of patients with ruptured and nonruptured abdominal aortic aneurysms. J. Vasc. Surg. 49, 455-463.
DOI
ScienceOn
|
48 |
Chew, P., Yuen, D. Y., Koh, P., Stefanovic, N., Febbraio, M. A., Kola, I., Cooper, M. E. and de Haan, J. B. (2009) Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 29, 823-830.
DOI
ScienceOn
|
49 |
Kim, J., Nam, K. H., Kim, S. O., Choi, J. H., Kim, H. C., Yang, S. D., Kang, J. H., Ryu, Y. H., Oh, G. T. and Yoo, S. E. (2004) KR-31378 ameliorates atherosclerosis by blocking monocyte recruitment in hypercholestrolemic mice. FASEB J. 18, 714-716.
DOI
|
50 |
Guo, Z., Ran, Q., Roberts, L. J., 2nd, Zhou, L., Richardson, A., Sharan, C., Wu, D. and Yang, H. (2008) Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice. Free. Radic. Biol. Med. 44, 343-352.
DOI
ScienceOn
|
51 |
Chae, H. Z., Kim, H. J., Kang, S. W. and Rhee, S. G. (1999) Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes. Res. Clin. Pract. 45, 101-112.
DOI
ScienceOn
|
52 |
Wang, X., Phelan, S. A., Petros, C., Taylor, E. F., Ledinski, G., Jurgens, G., Forsman-Semb, K. and Paigen, B. (2004) Peroxiredoxin 6 deficiency and atherosclerosis susceptibility in mice: significance of genetic background for assessing atherosclerosis. Atherosclerosis. 177, 61-70.
DOI
ScienceOn
|
53 |
Kisucka, J., Chauhan, A. K., Patten, I. S., Yesilaltay, A., Neumann, C., Van Etten, R. A., Krieger, M. and Wagner, D. D. (2008) Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ. Res. 103, 598-605.
DOI
ScienceOn
|
54 |
Rhee, S. G., Chae, H. Z. and Kim, K. (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free. Radic. Biol. Med. 38, 1543-1552.
DOI
ScienceOn
|
55 |
Conway, J. P. and Kinter, M. (2006) Dual role of peroxiredoxin I in macrophage-derived foam cells. J. Biol. Chem. 281, 27991-28001.
DOI
ScienceOn
|
56 |
Mowbray, A. L., Kang, D. H., Rhee, S. G., Kang, S. W. and Jo, H. (2008) Laminar shear stress up-regulates peroxiredoxins (PRX) in endothelial cells: PRX 1 as a mechanosensitive antioxidant. J. Biol. Chem. 283, 1622-1627.
DOI
ScienceOn
|
57 |
Lin, S. J., Shyue, S. K., Shih, M. C., Chu, T. H., Chen, Y. H., Ku, H. H., Chen, J. W., Tam, K. B. and Chen, Y. L. (2007) Superoxide dismutase and catalase inhibit oxidized low-density lipoprotein-induced human aortic smooth muscle cell proliferation: role of cell-cycle regulation, mitogen- activated protein kinases, and transcription factors. Atherosclerosis. 190, 124-134.
DOI
ScienceOn
|
58 |
Margis, R., Dunand, C., Teixeira, F. K. and Margis-Pinheiro, M. (2008) Glutathione peroxidase family - an evolutionary overview. FEBS J 275, 3959-3970.
DOI
ScienceOn
|
59 |
Wagner, A. H., Kautz, O., Fricke, K., Zerr-Fouineau, M., Demicheva, E., Guldenzoph, B., Bermejo, J. L., Korff, T. and Hecker, M. (2009) Upregulation of glutathione peroxidase offsets stretch-induced proatherogenic gene expression in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29, 1894-1901.
DOI
ScienceOn
|
60 |
Torzewski, M., Ochsenhirt, V., Kleschyov, A. L., Oelze, M., Daiber, A., Li, H., Rossmann, H., Tsimikas, S., Reifenberg, K., Cheng, F., Lehr, H. A., Blankenberg, S., Forstermann, U., Munzel, T. and Lackner, K. J. (2007) Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27, 850-857.
DOI
ScienceOn
|
61 |
Lewis, P., Stefanovic, N., Pete, J., Calkin, A. C., Giunti, S., Thallas-Bonke, V., Jandeleit-Dahm, K. A., Allen, T. J., Kola, I., Cooper, M. E. and de Haan, J. B. (2007) Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 115, 2178-2187.
DOI
ScienceOn
|
62 |
Blankenberg, S., Rupprecht, H. J., Bickel, C., Torzewski, M., Hafner, G., Tiret, L., Smieja, M., Cambien, F., Meyer, J. and Lackner, K. J. (2003) Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N. Engl. J. Med. 349, 1605-1613.
DOI
ScienceOn
|
63 |
Loeper, J., Goy, J., Rozensztajn, L., Bedu, O. and Moisson, P. (1991) Lipid peroxidation and protective enzymes during myocardial infarction. Clin. Chim. Acta. 196, 119-125.
DOI
ScienceOn
|
64 |
Rudijanto, A. (2007) The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta. Med. Indones 39, 86-93.
|
65 |
Grote, K., Flach, I., Luchtefeld, M., Akin, E., Holland, S. M., Drexler, H. and Schieffer, B. (2003) Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ. Res. 92, e80-86.
DOI
ScienceOn
|
66 |
Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G. and Galis, Z. S. (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98, 2572-2579.
DOI
ScienceOn
|
67 |
Yang, H., Roberts, L. J., Shi, M. J., Zhou, L. C., Ballard, B. R., Richardson, A. and Guo, Z. M. (2004) Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ. Res. 95, 1075-1081.
DOI
ScienceOn
|
68 |
De Keulenaer, G. W., Ushio-Fukai, M., Yin, Q., Chung, A. B., Lyons, P. R., Ishizaka, N., Rengarajan, K., Taylor, W. R., Alexander, R. W. and Griendling, K. K. (2000) Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alphamediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20, 385-391.
DOI
ScienceOn
|
69 |
von Harsdorf, R., Li, P. F. and Dietz, R. (1999) Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99, 2934-2941.
DOI
ScienceOn
|
70 |
Chelikani, P., Fita, I. and Loewen, P. C. (2004) Diversity of structures and properties among catalases. Cell. Mol. Life. Sci. 61, 192-208.
DOI
|
71 |
Han, K. Y., Kwon, T. H., Lee, T. H., Lee, S. J., Kim, S. H. and Kim, J. (2008) Suppressive effects of Lithospermum erythrorhizon extracts on lipopolysaccharide-induced activation of AP-1 and NF-kappaB via mitogen-activated protein kinase pathways in mouse macrophage cells. BMB Rep. 41, 328-333.
DOI
ScienceOn
|
72 |
Abate, C., Patel, L., Rauscher, F. J., 3rd and Curran, T. (1990) Redox regulation of fos and jun DNA-binding activity in vitro. Science. 249, 1157-1161.
DOI
|
73 |
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G. and Glass, C. K. (2005) Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707-721.
DOI
ScienceOn
|
74 |
Choi, M. H., Lee, I. K., Kim, G. W., Kim, B. U., Han, Y. H., Yu, D. Y., Park, H. S., Kim, K. Y., Lee, J. S., Choi, C., Bae, Y. S., Lee, B. I., Rhee, S. G. and Kang, S. W. (2005) Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 435, 347-353.
DOI
ScienceOn
|
75 |
Roebuck, K. A., Carpenter, L. R., Lakshminarayanan, V., Page, S. M., Moy, J. N. and Thomas, L. L. (1999) Stimulusspecific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J. Leukoc. Biol. 65, 291-298.
DOI
|
76 |
Taniyama, Y. and Griendling, K. K. (2003) Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42, 1075-1081.
DOI
ScienceOn
|
77 |
Bae, Y. S., Sung, J. Y., Kim, O. S., Kim, Y. J., Hur, K. C., Kazlauskas, A. and Rhee, S. G. (2000) Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 275, 10527-10531.
DOI
ScienceOn
|
78 |
Weber, D. S., Taniyama, Y., Rocic, P., Seshiah, P. N., Dechert, M. A., Gerthoffer, W. T. and Griendling, K. K. (2004) Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species- dependent regulation of platelet-derived growth factor- induced smooth muscle cell migration. Circ. Res. 94, 1219-1226.
DOI
ScienceOn
|
79 |
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., Lacy-Hulbert, A., El Khoury, J., Golenbock, D. T. and Moore, K. J. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155-161.
DOI
ScienceOn
|
80 |
Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N. and Witztum, J. L. (2003) Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278, 1561-1568.
DOI
ScienceOn
|
81 |
Forman, H. J. and Torres, M. (2002) Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care. Med. 166, S4-8.
DOI
ScienceOn
|
82 |
Miller, Y. I., Viriyakosol, S., Worrall, D. S., Boullier, A., Butler, S. and Witztum, J. L. (2005) Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler. Thromb. Vasc. Biol. 25, 1213-1219.
DOI
ScienceOn
|
83 |
Bae, Y. S., Lee, J. H., Choi, S. H., Kim, S., Almazan, F., Witztum, J. L. and Miller, Y. I. (2009) Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ. Res. 104, 210-218.
DOI
ScienceOn
|
84 |
Kamata, H. and Hirata, H. (1999) Redox regulation of cellular signalling. Cell. Signal. 11, 1-14.
DOI
ScienceOn
|
85 |
Rhee, J. W., Lee, K. W., Kim, D., Lee, Y., Jeon, O. H., Kwon, H. J. and Kim, D. S. (2007) NF-kappaB-dependent regulation of matrix metalloproteinase-9 gene expression by lipopolysaccharide in a macrophage cell line RAW 264.7. J. Biochem. Mol. Biol. 40, 88-94.
DOI
|
86 |
Chen, M., Masaki, T. and Sawamura, T. (2002) LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol. Ther. 95, 89-100.
DOI
ScienceOn
|
87 |
Manna, S. K., Zhang, H. J., Yan, T., Oberley, L. W. and Aggarwal, B. B. (1998) Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J. Biol. Chem. 273, 13245-13254.
DOI
ScienceOn
|
88 |
Yoshizumi, M., Fujita, Y., Izawa, Y., Suzaki, Y., Kyaw, M., Ali, N., Tsuchiya, K., Kagami, S., Yano, S., Sone, S. and Tamaki, T. (2004) Ebselen inhibits tumor necrosis factor- alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells. Exp. Cell. Res. 292, 1-10.
DOI
ScienceOn
|
89 |
Muller, J. M., Rupec, R. A. and Baeuerle, P. A. (1997) Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods. 11, 301-312.
DOI
ScienceOn
|
90 |
Yoon, J. J., Lee, Y. J., Kim, J. S., Kang, D. G. and Lee, H. S. (2010) Protective role of betulinic acid on TNF-alpha-induced cell adhesion molecules in vascular endothelial cells. Biochem. Biophys. Res. Commun. 391, 96-101.
DOI
ScienceOn
|
91 |
Park, J. G., Yoo, J. Y., Jeong, S. J., Choi, J. H., Lee, M. R., Lee, M. N., Lee, J. H., Kim, H. C., Jo, H., Yu, D. Y., Kang, S. W., Rhee, S. G., Lee, M. H. and Oh, G. T. (2011) Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice. Cir. Res. (In press).
|
92 |
Silverstein, R. L., Li, W., Park, Y. M. and Rahaman, S. O. (2010) Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis. Trans. Am. Clin. Climatol. Assoc. 121, 206-220.
|
93 |
Faucher, K., Rabinovitch-Chable, H., Barriere, G., Cook- Moreau, J. and Rigaud, M. (2003) Overexpression of cytosolic glutathione peroxidase (GPX1) delays endothelial cell growth and increases resistance to toxic challenges. Biochimie. 85, 611-617.
DOI
ScienceOn
|
94 |
Colavitti, R., Pani, G., Bedogni, B., Anzevino, R., Borrello, S., Waltenberger, J. and Galeotti, T. (2002) Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J. Biol. Chem. 277, 3101-3108.
DOI
ScienceOn
|
95 |
Abe, J., Okuda, M., Huang, Q., Yoshizumi, M. and Berk, B. C. (2000) Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras. J. Biol. Chem. 275, 1739-1748.
DOI
ScienceOn
|
96 |
Cominacini, L., Pasini, A. F., Garbin, U., Davoli, A., Tosetti, M. L., Campagnola, M., Rigoni, A., Pastorino, A. M., Lo Cascio, V. and Sawamura, T. (2000) Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J. Biol. Chem. 275, 12633-12638.
DOI
ScienceOn
|
97 |
Wung, B. S., Cheng, J. J., Chao, Y. J., Hsieh, H. J. and Wang, D. L. (1999) Modulation of Ras/Raf/extracellular signal-regulated kinase pathway by reactive oxygen species is involved in cyclic strain-induced early growth response- 1 gene expression in endothelial cells. Circ. Res. 84, 804-812.
DOI
ScienceOn
|
98 |
Zembowicz, A., Hatchett, R. J., Jakubowski, A. M. and Gryglewski, R. J. (1993) Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta. Br. J. Pharmacol. 110, 151-158.
DOI
ScienceOn
|
99 |
Yang, Z., Zhang, A., Altura, B. T. and Altura, B. M. (1999) Hydrogen peroxide-induced endothelium-dependent relaxation of rat aorta involvement of Ca2+ and other cellular metabolites. Gen. Pharmacol. 33, 325-336.
DOI
ScienceOn
|
100 |
Hancock, J. T., Desikan, R. and Neill, S. J. (2001) Role of reactive oxygen species in cell signalling pathways. Biochem. Soc. Trans. 29, 345-350.
DOI
ScienceOn
|
101 |
Allen, R. G. and Tresini, M. (2000) Oxidative stress and gene regulation. Free. Radic. Biol. Med. 28, 463-499.
DOI
ScienceOn
|
102 |
Kehrer, J. P. (2000) The Haber-Weiss reaction and mechanisms of toxicity. Toxicology. 149, 43-50.
DOI
ScienceOn
|
103 |
Sundaresan, M., Yu, Z. X., Ferrans, V. J., Irani, K. and Finkel, T. (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296-299.
DOI
ScienceOn
|